Trading Summary - December 9. Excellent development

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
231
Trading Summary - December 9.

Excellent development today with the filing of a Form 1Z Public Offering Exit Report now that the company is earning enough to not need to continue with it. It showed that $1.615M income would be added to the balance sheet and that 1.85 Billion of the A/S set aside for Public Offering purchase would not now be sold.

https://investorshangout.com/post/view?id=6297846

As a result, there was more upward progress today.

After an initial gap up to .0023, there were some minor games with small paint downs, shorting below the ask and walked down asks - all of which were dealt with by traders taking asks out with buys in the 1M > 1.5M range.

In the closing minutes, all except 87.5K of the .0025 were bought out and the remainder cancelled in the closing seconds - effectively closing at a .0026 ask.

Again today, aggressive outbidding stopped the scammer who had lost shares putting up walked down asks from reloading.

All significant trades were reported contemporaneously in earlier posts.

Overall, another 13.5M shares were bought today at bottom prices in the same broad range .0020 > .0052 (most of it at .0022 > .0025 today) as makes little difference at .01 > .02+. As predicted, top long term traders are more likely to buy 1M+ at each price point at current levels rather than 100K > 200K - and were seen to do so.

Since the loading at bottom prices total was restarted after the last run, 627.2M shares have been bought up to .0052 in 56 trading days September 22 - December 9 - 74.9% of the low Unrestricted Outstanding Shares count.

New interest traders / alerters + long-term traders with significant followings as at December 5 numbered at least 126 - up another 5 in the previous 7 days. List here:

https://investorshangout.com/post/view?id=6294940

Particular points they like are:

- Real revenue of $10M+ per year.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases.

- A ssets of $1.398M.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- Public Offering of 1.85 Billion shares cancelled - no longer required.

- How thin it is into the .01 > .02 range.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .062 > .1075 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .062 > .1075.

Every 1M bought at .0020 is worth a $8K profit at .01, $11K profit at .0130 and $18K profit at .02.

Every 1M bought at .0030 is worth a $7K profit at .01, $10K profit at .0130 and $17K profit at .02.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150 and $15K profit at .02.

Every 1M bought at .0050 is worth a $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated December 5 - here:

https://investorshangout.com/post/view?id=6294951

The anticipated revenue in 2021 - based on pro-rata of sales to date - is $10M+.

Additional inventory on the 1stDibs store at "BuyItNow" prices total of $331K.

$SFLM remains my #1 Top Profit Pick for the whole of 2021 and for me is currently #2 - flip flopping #1 - behind only $ENZC - due to the regular periodic surges.

It will now also be the #1 or #2 Top Profit Pick for the whole of 2022 (depending on $ENZC developments in the next 2 months).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

Nationwide expansion of the NFT Division continued on October 19 with the sign-up of a second regional based artist.

Also bear in mind that Q4 is traditionally the best Q each year due to Christmas shopping and supply chain issues in brick and mortar stores forcing more people to consider on-line purchases in good time.

The 2021 Q3 was filed after the close on November 15 - it was in line with the expectations of the top trader close followers of $SFLM with increased sales, increased gross profit, increased assets and vastly increased cash available for inventory purchase. Most importantly, the cash flow actually flipped positive for the first time ever - in Q3 rather than Q4 - where Q4 will obviously be even better than Q3.

2021 Q3 Key Points here:

https://investorshangout.com/post/view?id=6283945

Watch for the next PR soon which I would expect to cover the excellent Q3 results, the sales since October and November, and a ny developments from the CEO attending a NFT / crypto expo in Miama.

The Share Structure was updated after the close on December 7 - again showing no change and confirming no dilution - with the Unrestricted O/S remaining at a low 837M.

I added more batches today - all on the ask - and will continue to do so - both countering the manipulation attempts from the scammer(s) and buying up shares from the impatient.

Next auction to night - 240 items confirmed - so expect $200K > $250K+ again.

Again this week, there is already around $18K in pre-auction sales this week of higher priced items snapped up at "Buy It Now" prices.

Watch for a weekly sales update from the company after the close tomorrow.

I will then update the 2021 revenue total Friday evening and the DD as usual on Sunday.

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ACACIA's Big Move with Bel-Mac and Seashore: Will It Pay Off?

Updated Category News Views 19

A New Powerhouse in Roofing Services? Take a seat, folks—we're talking about a regional shakeup in the world of roofing and exterior building. ACACIA Exterior Building Group, based out of Alexandria, Virginia, just tightened its grip on the Mid-Atlantic and Gulf Coast markets by investing in Bel-Mac Roofing and Seashore Construction. This ain't just your run-of-the-mill...

Continue Reading
Historic Williamsburg Loft Gets a Modern Makeover

Updated Category News Views 46

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Continue Reading
Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 36

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
BJ's Brews a New Dessert Innovation with Pizookie

Updated Category News Views 49

Banana Bread Meets Nutella in BJ's Latest Pizookie Right off the bat, let's cut to the heart of this dessert innovation. BJ's Restaurant & Brewhouse, traded under NASDAQ:BJRI, has fired up its dessert menu with something new: the Nutella® Gone Bananas Pizookie®. This isn't just another sweet treat—it’s a bold move, and if you're wondering why, you're in good...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 0

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Updated Category News Views 70

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 106

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Virax Biolabs Expands China Reach With Key Partnerships

Updated Category News Views 68

Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....

Continue Reading
Farrin Firm Stands Out Again in Triangle's Fast 50

Updated Category News Views 27

Law Offices of James Scott Farrin in the Spotlight Another triumph for the Law Offices of James Scott Farrin. Not a newbie to recognition, this marks the third time in a row they've landed on the 'Triangle Business Journal's' esteemed 'Fast 50' list. They're the sole law firm among the Triangle's 50 fastest-growing private companies, making waves in a sea usually...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 55

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Against Jetstar for Misleading Passenger Rights

Updated Category News Views 207

Legal Action Against Jetstar for Misleading Passenger Rights New Zealand's competition authority is taking serious action against Jetstar, a low-cost airline operating under Qantas. They're in court over allegations that Jetstar misled its passengers about their rights to compensation due to delayed and cancelled flights. Allegations of Misleading Practices The New...

Continue Reading
Loona Petbot Commemorates Anniversary with User Engagement Surge

Updated Category News Views 197

Loona Petbot Commemorates Anniversary with Impressive User Engagement KEYi Technology is excited to share the remarkable success of its 1000-day anniversary celebration of the Loona Petbot. This event commenced recently and received an overwhelming response from users around the world. More than ten thousand participants engaged in the celebrations, showcasing the growing...

Continue Reading
Exploring Royce Small-Cap Trust: Current Insights and Trends

Updated Category News Views 145

Introduction to Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as a prominent name in the small-cap investment landscape, renowned for its commitment to long-term capital growth. Established as one of the oldest and largest closed-end funds focused on small-cap and micro-cap securities, this trust has carved a niche for itself among investors seeking...

Continue Reading
Grace Hill Teams with IWBI to Advance WELL Workspaces

Updated Category News Views 8

Pushing the Boundaries of Building Health The workplace is evolving, pal, and it ain't the stodgy cubicle farm it once was. Grace Hill, the technological maestro of real estate performance solutions, has shaken hands with the International WELL Building Institute (IWBI). This move ain't just about pushing a few papers but about bringing the occupant experience front and...

Continue Reading
Oppenheimer Upholds Outperform Rating for Tarsus Pharmaceuticals

Updated Category News Views 63

Oppenheimer Reaffirms Positive Outlook on Tarsus Pharmaceuticals Recently, Oppenheimer reiterated its favorable stance on Tarsus Pharmaceuticals (NASDAQ:TARS), affirming an Outperform rating coupled with a price target of $63. This endorsement comes ahead of the company's anticipated financial report for the third quarter of 2024, with special attention on the performance...

Continue Reading